Jun 9, 2026 02:00PM
Jun 3, 2026 04:01PM
Jun 3, 2026 04:01PM
May 8, 2026 07:30AM
May 7, 2026 04:01PM
Apr 30, 2026 07:30AM
Apr 10, 2026 07:00AM Verastem presents two-year follow-up data for ovarian cancer therapy
Apr 10, 2026 07:00AM
Mar 17, 2026 06:03PM
Mar 17, 2026 04:44PM
Mar 4, 2026 04:01PM
Feb 4, 2026 07:31AM
Feb 4, 2026 07:30AM
Dec 29, 2025 04:01PM Verastem discontinues lung cancer trial to focus on KRAS G12D program
Dec 29, 2025 04:01PM
Dec 15, 2025 04:01PM
Dec 15, 2025 04:01PM
Nov 14, 2025 12:41AM
Nov 14, 2025 12:41AM
Nov 13, 2025 04:07PM
Nov 13, 2025 04:07PM Verastem Oncology Announces Proposed Public Offering of Common Stock
Nov 4, 2025 07:30AM
Oct 23, 2025 04:01PM
Oct 23, 2025 04:01PM
Oct 19, 2025 04:15AM
Oct 19, 2025 04:15AM
Sep 11, 2025 08:18AM
Aug 13, 2025 04:29PM Verastem partner reports 68.8% response rate for lung cancer drug in China study
Aug 13, 2025 04:29PM
Aug 7, 2025 04:05PM
Jul 24, 2025 07:30AM
Jul 24, 2025 07:30AM
Jul 11, 2025 04:12PM
Jul 11, 2025 04:12PM
Jul 8, 2025 08:50AM Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Jun 30, 2025 04:02PM
Jun 30, 2025 04:02PM
Jun 24, 2025 04:02PM
Jun 24, 2025 04:02PM
May 22, 2025 05:07PM
May 22, 2025 05:01PM
May 20, 2025 08:33AM Tempus AI (TEM) Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
May 20, 2025 08:30AM
May 13, 2025 04:34PM
May 8, 2025 01:44PM
May 8, 2025 01:17PM
May 8, 2025 11:47AM
Apr 29, 2025 06:28AM
Apr 23, 2025 04:08PM Verastem Oncology (VSTM) Announces U.S. IND Clearance of VS-7375
Apr 23, 2025 04:05PM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All